[
  {
    "case_id": "M001",
    "age": 67,
    "sex": "F",
    "diagnosis": "Type 2 diabetes",
    "diagnosis_source": "Diagnosis confirmed based on repeated elevated HbA1c measurements, fasting blood glucose levels and clinical history of progressive polyuria and weight change.",
    "primary_symptom": "Fatigue",
    "primary_symptom_source": "Patient reports persistent fatigue over the last six months, interfering with daily activities and worsening in the late afternoon and evenings.",
    "comorbidity": "Hypertension",
    "comorbidity_source": "Longstanding history of primary hypertension managed in outpatient clinic with stable blood pressure under current medication regimen.",
    "medication": "Metformin",
    "medication_source": "First-line oral hypoglycemic agent prescribed according to international diabetes management guidelines for newly diagnosed patients.",
    "dosage": "500 mg bid",
    "dosage_source": "Initial low dose regimen chosen to minimize gastrointestinal side effects while maintaining adequate glycemic control targets.",
    "outcome": "Stable",
    "outcome_source": "Glycemic markers and blood pressure readings remained stable over three consecutive follow-up visits without acute complications.",
    "risk_score": 0.62,
    "risk_score_source": "Composite risk score calculated from age, BMI, blood pressure and lipid profile using internal cardiovascular risk model."
  },
  {
    "case_id": "M002",
    "age": 54,
    "sex": "M",
    "diagnosis": "Acute myocardial infarction",
    "diagnosis_source": "Confirmed by elevated cardiac troponin levels, characteristic ECG changes and typical chest pain presentation at admission.",
    "primary_symptom": "Chest pain",
    "primary_symptom_source": "Sudden onset retrosternal chest pain radiating to the left arm, persisting longer than thirty minutes and not relieved by rest.",
    "comorbidity": "Hyperlipidemia",
    "comorbidity_source": "Documented elevated LDL cholesterol and triglyceride levels on multiple lab measurements over the past two years.",
    "medication": "Aspirin",
    "medication_source": "Administered as immediate antiplatelet therapy in accordance with acute coronary syndrome treatment guidelines.",
    "dosage": "300 mg once",
    "dosage_source": "Loading dose given at emergency presentation to achieve rapid platelet inhibition before catheterization.",
    "outcome": "Improved",
    "outcome_source": "ST-segment elevation resolved and cardiac biomarkers trended down after successful percutaneous coronary intervention.",
    "risk_score": 0.87,
    "risk_score_source": "High risk category determined using hospital-specific post-infarction risk stratification calculator combining multiple clinical features."
  },
  {
    "case_id": "M003",
    "age": 29,
    "sex": "F",
    "diagnosis": "Community-acquired pneumonia",
    "diagnosis_source": "Diagnosis based on fever, productive cough, auscultation findings and chest X-ray demonstrating patchy infiltrates.",
    "primary_symptom": "Cough",
    "primary_symptom_source": "Productive cough with yellow sputum lasting for ten days, associated with mild shortness of breath during exertion.",
    "comorbidity": "None",
    "comorbidity_source": "No relevant chronic illnesses or prior hospitalizations were reported or documented in the electronic health record.",
    "medication": "Amoxicillin",
    "medication_source": "Empiric antibiotic therapy selected according to local resistance patterns for low-risk community-acquired pneumonia.",
    "dosage": "875 mg bid",
    "dosage_source": "Standard adult dosage recommended for uncomplicated lower respiratory tract infection over a seven day treatment course.",
    "outcome": "Recovered",
    "outcome_source": "Symptoms resolved completely and follow-up examination showed clear lung sounds without residual abnormal findings.",
    "risk_score": 0.21,
    "risk_score_source": "Low clinical risk derived from age, comorbidity profile and absence of hemodynamic instability at presentation."
  },
  {
    "case_id": "M004",
    "age": 73,
    "sex": "M",
    "diagnosis": "Chronic kidney disease",
    "diagnosis_source": "Persistently reduced estimated glomerular filtration rate and structural changes observed on renal ultrasound imaging.",
    "primary_symptom": "Edema",
    "primary_symptom_source": "Progressive lower limb swelling reported over several months, worse in the evening and improving partially with rest.",
    "comorbidity": "Diabetes mellitus",
    "comorbidity_source": "Long history of poorly controlled diabetes with prior documentation of microalbuminuria and retinopathy.",
    "medication": "ACE inhibitor",
    "medication_source": "Renoprotective therapy initiated to reduce intraglomerular pressure and slow the progression of kidney function decline.",
    "dosage": "10 mg qd",
    "dosage_source": "Dose titrated from a lower starting dose to achieve target blood pressure without inducing symptomatic hypotension.",
    "outcome": "Stable",
    "outcome_source": "Renal function remained within the same chronic disease stage across three follow-up lab assessments.",
    "risk_score": 0.74,
    "risk_score_source": "Risk score generated by internal model integrating eGFR trends, albuminuria and comorbid cardiovascular conditions."
  },
  {
    "case_id": "M005",
    "age": 45,
    "sex": "F",
    "diagnosis": "Major depressive disorder",
    "diagnosis_source": "Diagnosis made following structured psychiatric interview and standardized depression rating scale exceeding diagnostic threshold.",
    "primary_symptom": "Low mood",
    "primary_symptom_source": "Persistent low mood, anhedonia and difficulty concentrating reported nearly every day for more than two months.",
    "comorbidity": "Generalized anxiety",
    "comorbidity_source": "Chronic excessive worry and physical tension documented in prior mental health visits and questionnaire scores.",
    "medication": "SSRI",
    "medication_source": "First-line antidepressant class prescribed according to contemporary practice guidelines for moderate depressive episodes.",
    "dosage": "20 mg qd",
    "dosage_source": "Starting dose chosen to minimize side effects with plan to reassess for titration based on clinical response.",
    "outcome": "Partial response",
    "outcome_source": "Symptom severity scores decreased but did not reach full remission thresholds after eight weeks of treatment.",
    "risk_score": 0.56,
    "risk_score_source": "Risk score derived from baseline severity, comorbid anxiety and history of prior depressive episodes.",
    "risk_score_source": "Risk estimate derived from baseline severity, comorbid anxiety and prior depressive episode history combined."
  },
  {
    "case_id": "M006",
    "age": 61,
    "sex": "M",
    "diagnosis": "Chronic obstructive pulmonary disease",
    "diagnosis_source": "Confirmed with spirometry demonstrating irreversible airflow limitation consistent with GOLD criteria for COPD.",
    "primary_symptom": "Dyspnea",
    "primary_symptom_source": "Progressive shortness of breath on exertion, limiting walking distance and requiring frequent rest during activities.",
    "comorbidity": "Smoking history",
    "comorbidity_source": "Long-term daily smoker with over forty pack-years documented in social history and counseling notes.",
    "medication": "LABA/LAMA inhaler",
    "medication_source": "Combination bronchodilator therapy initiated to improve airflow and reduce frequency of exacerbations.",
    "dosage": "2 puffs bid",
    "dosage_source": "Standard inhaler regimen recommended by manufacturer for maintenance treatment of chronic obstructive symptoms.",
    "outcome": "Improved",
    "outcome_source": "Reported exercise tolerance increased and rescue inhaler use decreased according to follow-up clinic documentation.",
    "risk_score": 0.69,
    "risk_score_source": "Risk score incorporates exacerbation history, spirometry values and smoking exposure to estimate future flare probability."
  },
  {
    "case_id": "M007",
    "age": 38,
    "sex": "F",
    "diagnosis": "Autoimmune thyroiditis",
    "diagnosis_source": "Positive thyroid autoantibodies, ultrasound features and elevated TSH levels consistent with Hashimoto thyroiditis.",
    "primary_symptom": "Weight gain",
    "primary_symptom_source": "Gradual weight gain and cold intolerance reported over several months before endocrine evaluation.",
    "comorbidity": "None",
    "comorbidity_source": "No additional chronic illnesses documented and family history is negative for major endocrine disorders.",
    "medication": "Levothyroxine",
    "medication_source": "Synthetic thyroid hormone replacement selected to normalize TSH and relieve hypothyroid symptoms.",
    "dosage": "75 mcg qd",
    "dosage_source": "Weight-based dosing calculated and then slightly adjusted to accommodate patient sensitivity and lab response.",
    "outcome": "Recovered",
    "outcome_source": "TSH normalized and clinical symptoms largely resolved at twelve week follow-up visit.",
    "risk_score": 0.33,
    "risk_score_source": "Low risk category assigned due to early diagnosis, good adherence and absence of significant comorbid conditions."
  },
  {
    "case_id": "M008",
    "age": 82,
    "sex": "M",
    "diagnosis": "Atrial fibrillation",
    "diagnosis_source": "Irregularly irregular rhythm on ECG and history of palpitations confirmed paroxysmal atrial fibrillation.",
    "primary_symptom": "Palpitations",
    "primary_symptom_source": "Episodes of rapid, irregular heartbeat lasting several minutes, sometimes associated with mild dizziness.",
    "comorbidity": "Heart failure",
    "comorbidity_source": "Reduced ejection fraction documented on echocardiography with prior admissions for decompensated heart failure.",
    "medication": "DOAC",
    "medication_source": "Direct oral anticoagulant prescribed for stroke prevention according to current atrial fibrillation guidelines.",
    "dosage": "5 mg bid",
    "dosage_source": "Dose selected based on renal function and body weight, following manufacturer and guideline recommendations.",
    "outcome": "Stable",
    "outcome_source": "No thromboembolic events or major bleeding episodes reported during twelve month follow-up.",
    "risk_score": 0.91,
    "risk_score_source": "High thromboembolic risk determined by CHA2DS2-VASc score using age, heart failure and comorbidity factors."
  },
  {
    "case_id": "M009",
    "age": 23,
    "sex": "F",
    "diagnosis": "Migraine without aura",
    "diagnosis_source": "Recurrent unilateral headache episodes fulfilling International Classification of Headache Disorders criteria.",
    "primary_symptom": "Headache",
    "primary_symptom_source": "Throbbing unilateral headaches lasting several hours, aggravated by activity and accompanied by photophobia.",
    "comorbidity": "None",
    "comorbidity_source": "No significant medical history or chronic medication use documented in the health record.",
    "medication": "Triptan",
    "medication_source": "Acute abortive therapy chosen for moderate to severe migraine attacks unresponsive to simple analgesics.",
    "dosage": "50 mg prn",
    "dosage_source": "Taken at onset of headache, with repeat dosing limited according to recommended maximum daily amount.",
    "outcome": "Improved",
    "outcome_source": "Attack frequency decreased and responsiveness to early triptan use improved over three month follow-up.",
    "risk_score": 0.18,
    "risk_score_source": "Low long-term risk since structural brain imaging was normal and there are no additional neurological deficits."
  },
  {
    "case_id": "M010",
    "age": 59,
    "sex": "M",
    "diagnosis": "Rheumatoid arthritis",
    "diagnosis_source": "Diagnosis supported by positive rheumatoid factor, anti-CCP antibodies and characteristic joint involvement pattern.",
    "primary_symptom": "Joint pain",
    "primary_symptom_source": "Symmetric small joint pain and morning stiffness lasting more than one hour for several months.",
    "comorbidity": "Anemia of chronic disease",
    "comorbidity_source": "Mild normocytic anemia documented on multiple complete blood counts during inflammatory flares.",
    "medication": "Methotrexate",
    "medication_source": "Conventional synthetic disease-modifying antirheumatic drug initiated as first-line controller therapy.",
    "dosage": "15 mg weekly",
    "dosage_source": "Once-weekly oral dosing chosen with concurrent folic acid supplementation to reduce adverse effects.",
    "outcome": "Partial response",
    "outcome_source": "Joint counts and inflammatory markers improved but residual stiffness persists according to follow-up notes.",
    "risk_score": 0.63,
    "risk_score_source": "Prognostic score combines seropositivity, baseline erosions and early response to therapy into a single index."
  }
]
